Altered fibrinolysis in autosomal dominant thrombomodulin-associated coagulopathy
| dc.contributor.author | Burley, Kate | |
| dc.contributor.author | Whyte, Claire S. | |
| dc.contributor.author | Westbury, Sarah K. | |
| dc.contributor.author | Walker, Mary | |
| dc.contributor.author | Stirrups, Kathleen E | |
| dc.contributor.author | Turro, Ernest | |
| dc.contributor.author | Chapman, Oliver | |
| dc.contributor.author | Reilly-Stitt, Christopher | |
| dc.contributor.author | Mutch, Nicola J. | |
| dc.contributor.author | Mumford, Andrew D. | |
| dc.contributor.institution | University of Aberdeen.Applied Medicine | en |
| dc.contributor.institution | University of Aberdeen.Medical Sciences - Cardiovascular Group | en |
| dc.date.accessioned | 2017-07-19T23:01:14Z | |
| dc.date.available | 2017-07-19T23:01:14Z | |
| dc.date.issued | 2016-10-06 | |
| dc.description | The NIHR BioResource-Rare Diseases and the ThromboGenomics sequencing projects are supported by the National Institute for Health Research (NIHR; http://www.nihr.ac.uk). KB is an NIHR academic clinical fellow. SKW is supported by a Medical Research Council (MRC) Clinical Training Fellowship (MR/K023489/1). KS and ET are supported by the NIHR BioResource Rare Diseases. CSW and NJM are supported by the British Heart Foundation (FS/11/2/28579). ADM is supported by the NIHR Bristol Cardiovascular Biomedical Research Unit. Deposited in EuropePMC. PMCID:PMC5054699 | en |
| dc.description.status | Peer reviewed | en |
| dc.format.extent | 5 | |
| dc.format.extent | 1485737 | |
| dc.identifier | 69510430 | |
| dc.identifier | 08b01569-12f4-4162-b731-e7018b74d516 | |
| dc.identifier | 85030419067 | |
| dc.identifier.citation | Burley, K, Whyte, C S, Westbury, S K, Walker, M, Stirrups, K E, Turro, E, Chapman, O, Reilly-Stitt, C, Mutch, N J & Mumford, A D 2016, 'Altered fibrinolysis in autosomal dominant thrombomodulin-associated coagulopathy', Blood, vol. 128, no. 14, pp. 1879-1883. https://doi.org/10.1182/blood-2016-05-716092 | en |
| dc.identifier.doi | 10.1182/blood-2016-05-716092 | |
| dc.identifier.iss | 14 | en |
| dc.identifier.issn | 0006-4971 | |
| dc.identifier.other | ORCID: /0000-0001-8127-6102/work/101050686 | |
| dc.identifier.other | ORCID: /0000-0002-7452-0813/work/169538882 | |
| dc.identifier.uri | http://hdl.handle.net/2164/8972 | |
| dc.identifier.url | http://europepmc.org/abstract/MED/27436851 | en |
| dc.identifier.vol | 128 | en |
| dc.language.iso | eng | |
| dc.relation.ispartof | Blood | en |
| dc.subject | R Medicine | en |
| dc.subject | Medical Research Council (MRC) | en |
| dc.subject | MR/K023489/1 | en |
| dc.subject | British Heart Foundation | en |
| dc.subject | FS/11/2/28579 | en |
| dc.subject | National Institute for Health Research (NIHR) | en |
| dc.subject.lcc | R | en |
| dc.title | Altered fibrinolysis in autosomal dominant thrombomodulin-associated coagulopathy | en |
| dc.type | Journal article | en |
